当前位置:首页 - 行情中心 - 威尔药业(603351) - 财务分析

威尔药业

(603351)

  

流通市值:38.60亿  总市值:38.60亿
流通股本:1.35亿   总股本:1.35亿

威尔药业(603351)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.71亿元,每股收益0.54元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益172531.98万元,未分配利润57428.99万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产249253.09万元,负债76721.10万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入673,722,955.67349,725,188.551,296,753,389.061,000,364,429.23
营业总成本588,979,381.47307,861,914.391,137,417,233.03886,687,537.69
其他经营收益
营业利润85,951,118.5143,019,332.36172,350,437.39128,898,149.74
利润总额85,856,645.4942,949,715.49172,131,263.87128,731,004.47
净利润71,302,630.4635,766,178.54145,205,838.7111,031,186.3
每股收益
其他综合收益----
综合收益总额71,302,630.4635,766,178.54145,205,838.7111,031,186.3
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计791,592,373.74734,995,021.33717,205,052.03599,216,567.22
非流动资产:
非流动资产合计1,700,938,485.991,688,996,630.371,663,708,867.641,680,220,842.31
资产总计2,492,530,859.732,423,991,651.72,380,913,919.672,279,437,409.53
流动负债:
流动负债合计668,393,125.94583,245,290.13595,900,957.25516,054,200.84
非流动负债:
非流动负债合计98,817,892.3996,259,346.5576,814,704.8387,546,924.45
负债合计767,211,018.33679,504,636.68672,715,662.08603,601,125.29
所有者权益(或股东权益):
归属于母公司股东权益合计1,720,509,672.331,739,034,006.51,701,923,864.461,670,212,016.14
股东权益合计1,725,319,841.41,744,487,015.021,708,198,257.591,675,836,284.24
负债和股东权益合计2,492,530,859.732,423,991,651.72,380,913,919.672,279,437,409.53
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计540,300,302.45268,677,131.121,099,680,714.3842,784,174.82
经营活动现金流出小计466,025,685.03246,465,675.22877,887,268.84681,578,988.5
经营活动产生的现金流量净额74,274,617.4222,211,455.9221,793,445.46161,205,186.32
投资活动产生的现金流量:
投资活动现金流入小计900,000900,0009,976,968.548,569,933.36
投资活动现金流出小计72,797,235.0850,525,198.8380,457,885.174,075,153.98
投资活动产生的现金流量净额-71,897,235.08-49,625,198.83-70,480,916.56-65,505,220.62
筹资活动产生的现金流量:
筹资活动现金流入小计309,000,000121,000,000381,020,400242,886,361.11
筹资活动现金流出小计304,653,300.1597,395,728.17444,052,234.79326,903,030.08
筹资活动产生的现金流量净额4,346,699.8523,604,271.83-63,031,834.79-84,016,668.97
汇率变动对现金及现金等价物的影响342,762.81-2,456.451,373,441.63636,376.69
现金及现金等价物净增加额7,066,845-3,811,927.5589,654,135.7412,319,673.42
期末现金及现金等价物余额254,267,327.38243,388,554.83247,200,482.38169,866,020.06
补充资料:
现金及现金等价物的净增加额7,066,845-89,654,135.74-
最新报告期:2025-08-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
山西证券魏赟1.261.782.412025-08-26
TOP↑